Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.
Br J Dermatol. 2021 Mar;184(3):425-436. doi: 10.1111/bjd.19262. Epub 2020 Dec 16.
Br J Dermatol. 2021.
PMID: 32479641
Clinical Trial.